fda glp-1 warning letters november 2025 issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's September crackdown on misleading March 31, 2025: Senator asks

Medications can interact in many different ways

Unlike broader-spectrum GHSs, ipamorelin targets the growth hormone secretagogue receptor (GHSR) with high specificity, with preclinical models showing minimal impact on ACTH or cortisol [peptidedosages.com]

Swapping refined grains with high-fiber whole grains can also help support your weight loss journey and improve overall health

-arrestins have been shown to function as critical adaptors for agonist-induced endocytosis of GPCRs [56,57], and as important adaptors for agonist-induced ubiquitination of GPCRs [58,59], and scaffold MAPK cascades such as ERK1/2 and JNK3 within endosomes [60]

It's about respecting the power of the medication and partnering with a clinical team that respects your health

In randomized trials, GLP-1s produce placebo-adjusted weight reduction of 5% to 18% among individuals with obesity or overweight and weight-related complications